Considering the large number of type I fibers in humans [22–24] and the additional shift in fiber type distribution of nebulin-deficient muscle and NEM patients toward type I fibers [12–15], OM might be a therapeutic option to ameliorate the muscle weakness in NEM patients. The gene discussed is NEB; the disease is ocular melanoma.